Viemed Healthcare (VMD) EBITDA (2018 - 2026)

Viemed Healthcare's EBITDA history runs 9 years deep, the most recent figure standing at $4.3 million for Q1 2026.

• Quarterly EBITDA rose 11.85% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.4 million (up 19.79% YoY) and the FY2025 annual result came in at $22.9 million, up 28.21% from the prior year.
• EBITDA was $4.3 million for Q1 2026 at Viemed Healthcare, down from $8.4 million in the prior quarter.
• Across five years, EBITDA topped out at $8.4 million in Q4 2025 and bottomed at $1.2 million in Q2 2022.
• A 5-year average of $4.1 million and a median of $3.8 million in 2025 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA tumbled 56.67% — and 2023, when it soared 162.78%.
• Viemed Healthcare's EBITDA stood at $3.8 million in 2022, then soared by 40.11% to $5.3 million in 2023, then rose by 21.99% to $6.5 million in 2024, then advanced by 29.74% to $8.4 million in 2025, then sank by 48.68% to $4.3 million in 2026.
• Business Quant data shows VMD's EBITDA at $4.3 million in Q1 2026, $8.4 million in Q4 2025, and $5.6 million in Q3 2025.